Cargando…

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection

Several studies have shown that neutralizing antibody levels correlate with immune protection from COVID-19 and have estimated the relationship between neutralizing antibodies and protection. However, results of these studies vary in terms of estimates of the level of neutralizing antibodies require...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoury, David S., Schlub, Timothy E., Cromer, Deborah, Steain, Megan, Fong, Youyi, Gilbert, Peter B., Subbarao, Kanta, Triccas, James A., Kent, Stephen J., Davenport, Miles P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881762/ https://www.ncbi.nlm.nih.gov/pubmed/36692375 http://dx.doi.org/10.3201/eid2902.221422

Ejemplares similares

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022)

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2023)

Monoclonal antibody levels and protection from COVID-19
por: Stadler, Eva, et al.
Publicado: (2023)

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
por: Roozendaal, Ramon, et al.
Publicado: (2020)

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
por: Khoury, David S., et al.
Publicado: (2020)

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
por: Bockstal, Viki, et al.
Publicado: (2022)

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
por: Kent, Stephen J., et al.
Publicado: (2022)

HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells
por: Cromer, Deborah, et al.
Publicado: (2016)

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report
por: Waheed, Dur-e-Nayab, et al.
Publicado: (2023)

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021)

chngpt: threshold regression model estimation and inference
por: Fong, Youyi, et al.
Publicado: (2017)

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Wheatley, Adam K., et al.
Publicado: (2021)

Population heterogeneity in Plasmodium vivax relapse risk
por: Stadler, Eva, et al.
Publicado: (2022)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study
por: Tawinprai, Kriangkrai, et al.
Publicado: (2022)

A threshold method for immunological correlates of protection
por: Chen, Xuan, et al.
Publicado: (2013)

Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
por: Baz, Mariana, et al.
Publicado: (2015)

Reduced erythrocyte susceptibility and increased host clearance of young parasites slows Plasmodium growth in a murine model of severe malaria
por: Khoury, David S., et al.
Publicado: (2015)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

Erratum to: A threshold method for immunological correlates of protection
por: Chen, Xuan, et al.
Publicado: (2017)

Predicting CD62L expression during the CD8+ T cell response in vivo
por: Schlub, Timothy E., et al.
Publicado: (2009)

Where Have All the Parasites Gone? Modelling Early Malaria Parasite Sequestration Dynamics
por: Cromer, Deborah, et al.
Publicado: (2013)

SARS Vaccine Protective in Mice
por: Stadler, Konrad, et al.
Publicado: (2005)

Accurately Measuring Recombination between Closely Related HIV-1 Genomes
por: Schlub, Timothy E., et al.
Publicado: (2010)

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
por: Pymm, Phillip, et al.
Publicado: (2021)

Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
por: Stewart, Erica L., et al.
Publicado: (2022)

A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial
por: Baisley, Kathy J., et al.
Publicado: (2021)

Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants
por: Reynaldi, Arnold, et al.
Publicado: (2019)

Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial
por: Fong, Youyi, et al.
Publicado: (2023)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Modeling the dynamics of neonatal CD8+ T cell responses
por: Reynaldi, Arnold, et al.
Publicado: (2016)

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
por: Yang, Zhi-yong, et al.
Publicado: (2004)

A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library
por: Waugh, Caryll, et al.
Publicado: (2015)

Preferential selection of viral escape mutants by CD8(+) T cell ‘sieving’ of SIV reactivation from latency
por: Docken, Steffen S., et al.
Publicado: (2023)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice
por: Ashhurst, Anneliese S., et al.
Publicado: (2022)

Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data
por: Stadler, Eva, et al.
Publicado: (2023)

Workshop on Radiation Protection on the Threshold of 21st Century
Publicado: (1994)

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial
por: Baisley, Kathy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6hr5stddoop0ckp52mr6rpn7aj